Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Oncology|September 12, 2022
An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genesAlison Schwartz, Danielle K Manning, Diane R Koeller, et al.
Familial Cancer|June 21, 2023
Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal CancerRachel Hodan, Linda Rodgers-Fouche, Anu Chittenden, et al.
Cancers|March 13, 2024
Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor GenomesHuma Q Rana, Diane R Koeller, McKenzie Walker, et al.
Frontiers in Oncology|February 12, 2024
Development and evaluation of INT<sup>2</sup>GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndromeRaymond A Isidro, Anu Chittenden, McKenzie Walker, et al.
Journal of the National Cancer Institute|June 6, 2002
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRODavid M Euhus, Kristin C Smith, Linda Robinson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing ProgramBrittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Cancers|July 12, 2025
Advancing the Landscape of Clinical Actionability in Von Hippel-Lindau Syndrome: An Evidence-Based Framework from the INT<sup>2</sup>GRATE Oncology ConsortiumDiane R Koeller, McKenzie Walker, Busra Unal, et al.
Cancers|May 28, 2022
Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond <i>BRCA1</i> and <i>BRCA2</i> in Breast and Ovarian Cancer PatientsWhitney Espinel, Marjan Champine, Heather Hampel, et al.
Pageof 3